Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Gastro Hep Advances
|
January 16, 2026
Gas-forming Pyogenic Liver Abscess Mimicking Gastric Perforation in a Patient With Diabetic Ketoacidosis and Subsequent Rupture: A Case Report
Tairyu Sato, Koki Yamada, Akira Nishio, et al.
Plos One
|
December 21, 2022
Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
Kumiko Shirai, Hayato Hikita, Ryotaro Sakamori, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma
Akira Nishio, Takahiro Kodama, Kazuma Daiku, et al.
Cancers
|
January 21, 2023
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, et al.
Plos Pathogens
|
May 12, 2017
Characterization of miR-122-independent propagation of HCV
Chikako Ono, Takasuke Fukuhara, Daisuke Motooka, et al.
Gastro Hep Advances
|
January 26, 2026
Contrast-Enhanced Ultrasound and Somatostatin Receptor Scintigraphy Unveil an Occult Neuroendocrine Tumor With Carcinoid Syndrome and Presumed Small Intestinal Origin - A Case Report
Tairyu Sato, Akira Nishio, Tadashi Kegasawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 18, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
Emi Sometani, Hayato Hikita, Kazuhiro Murai, et al.
BMC Gastroenterology
|
May 1, 2026
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliteration
Kazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology (Baltimore, Md.)
|
January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma
Shuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Journal for Immunotherapy of Cancer
|
April 9, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Yu Sato, Takahiro Kodama, Kazuki Maesaka, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Gastro Hep Advances
|
January 16, 2026
Gas-forming Pyogenic Liver Abscess Mimicking Gastric Perforation in a Patient With Diabetic Ketoacidosis and Subsequent Rupture: A Case Report
Tairyu Sato, Koki Yamada, Akira Nishio, et al.
Plos One
|
December 21, 2022
Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis
Kumiko Shirai, Hayato Hikita, Ryotaro Sakamori, et al.
Journal for Immunotherapy of Cancer
|
March 30, 2026
Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma
Akira Nishio, Takahiro Kodama, Kazuma Daiku, et al.
Cancers
|
January 21, 2023
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral
Takayuki Matsumae, Takahiro Kodama, Yuki Tahata, et al.
Plos Pathogens
|
May 12, 2017
Characterization of miR-122-independent propagation of HCV
Chikako Ono, Takasuke Fukuhara, Daisuke Motooka, et al.
Gastro Hep Advances
|
January 26, 2026
Contrast-Enhanced Ultrasound and Somatostatin Receptor Scintigraphy Unveil an Occult Neuroendocrine Tumor With Carcinoid Syndrome and Presumed Small Intestinal Origin - A Case Report
Tairyu Sato, Akira Nishio, Tadashi Kegasawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 18, 2024
High serum growth differentiation factor 15 is a risk factor for the occurrence of hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs
Emi Sometani, Hayato Hikita, Kazuhiro Murai, et al.
BMC Gastroenterology
|
May 1, 2026
Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliteration
Kazuma Shinkai, Ryotaro Sakamori, Ryoko Yamada, et al.
Hepatology (Baltimore, Md.)
|
January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma
Shuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Journal for Immunotherapy of Cancer
|
April 9, 2026
Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Yu Sato, Takahiro Kodama, Kazuki Maesaka, et al.
Page
of 6